Published October 2018
| Version v1
Journal article
The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis
Creators
- 1. Division of Cardiology, Denver VA Medical Center and University of Colorado, Denver (United States)
- 2. Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY (United States)
- 3. 1st Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki (Greece)
- 4. Division of Cardiology, Medstar, Washington Hospital Center, DC (United States)
- 5. Cardiology Working Group, Society of Junior Doctors, Athens (Greece)
Description
Transcatheter aortic valve implantation (TAVI) is a safe and effective alternative to surgical aortic valve replacement (SAVR) for the treatment of severe aortic valve stenosis (AS). The impact of concomitant baseline elevated pulmonary artery pressures on outcomes after TAVI has not been established, since different studies used different definitions of pulmonary hypertension (PH).
Additional details
Identifiers
- DOI
- 10.1016/j.carrev.2018.03.015;
- PII
- S1553838918301180;
Publishing Information
- Journal Title
- Cardiovascular Revascularization Medicine (Print)
- Journal Volume
- 19
- Journal Issue
- 7
- Journal Page Range
- p. 859-867
- ISSN
- 1553-8389
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 55055137
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ARTERIES; HYPERTENSION; MORTALITY; PATIENTS; PH VALUE; REVIEWS; SURGERY
- Descriptors DEC
- BLOOD VESSELS; BODY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DISEASES; DOCUMENT TYPES; MEDICINE; ORGANS; SYMPTOMS; VASCULAR DISEASES
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.